PUBLISHER: The Business Research Company | PRODUCT CODE: 1947095
PUBLISHER: The Business Research Company | PRODUCT CODE: 1947095
Robotic-assisted eye surgery refers to procedures in which robotic systems or tools are used to support ophthalmic surgeons in carrying out highly precise and minimally invasive eye operations. These technologies improve the surgeon's abilities by offering enhanced precision, stability, and control, which are especially critical for delicate and complex interventions involving the retina, cornea, or other ocular structures.
The primary categories of robotic-assisted eye surgery include robotic systems, instruments and accessories, as well as software and services. Robotic systems are integrated setups combining mechanical parts, sensors, control mechanisms, and software, designed to perform tasks either automatically or semi-automatically with high precision, consistency, and minimal human input. The surgeries involved include cataract surgery, retinal surgery, corneal surgery, glaucoma surgery, refractive surgery, and others, utilizing technologies such as haptic feedback systems, image-guided platforms, AI-powered robotic systems, and more. These procedures are applied in anterior segment surgeries, posterior segment surgeries, corneal surgeries, and other applications, serving a range of end users including hospitals, ambulatory surgical centers (ASCs), specialized ophthalmic clinics, and academic or research institutions.
Tariffs are impacting the robotic-assisted eye surgery market by increasing costs for imported robotic components, precision instruments, and advanced imaging systems. Segments such as robotic systems and image-guided technologies are most affected, particularly in regions like Asia-Pacific and Europe that rely on cross-border supply chains. These cost pressures can slow adoption in emerging markets; however, tariffs are also encouraging local manufacturing, regional partnerships, and innovation in cost-efficient robotic platforms, strengthening long-term market sustainability.
The robotic-assisted eye surgery market research report is one of a series of new reports from The Business Research Company that provides robotic-assisted eye surgery market statistics, including robotic-assisted eye surgery industry global market size, regional shares, competitors with a robotic-assisted eye surgery market share, detailed robotic-assisted eye surgery market segments, market trends and opportunities, and any further data you may need to thrive in the robotic-assisted eye surgery industry. This robotic-assisted eye surgery market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.
The robotic-assisted eye surgery market size has grown rapidly in recent years. It will grow from $1.39 billion in 2025 to $1.59 billion in 2026 at a compound annual growth rate (CAGR) of 14.4%. The growth in the historic period can be attributed to limitations of manual microsurgical techniques, increasing prevalence of cataract and retinal disorders, growth in specialized eye care centers, rising surgeon demand for enhanced precision tools, gradual adoption of computer-assisted ophthalmic systems.
The robotic-assisted eye surgery market size is expected to see rapid growth in the next few years. It will grow to $2.66 billion in 2030 at a compound annual growth rate (CAGR) of 13.7%. The growth in the forecast period can be attributed to advancements in AI-driven robotic systems, increasing aging population with eye disorders, expansion of ambulatory surgical centers, growing investments in ophthalmic robotics R&D, wider acceptance of robot-assisted procedures by surgeons. Major trends in the forecast period include rising adoption of minimally invasive ophthalmic procedures, increasing demand for high-precision and stable surgical outcomes, growing use of robotic assistance in complex retinal and corneal surgeries, expansion of training and skill enhancement programs for surgeons, higher focus on patient safety and reduced surgical variability.
The growing prevalence of eye disorders is expected to drive the expansion of the robotic-assisted eye surgery market in the coming years. Eye disorders are medical conditions that impact the structure or function of the eye, potentially resulting in vision impairment or blindness. The rise in such conditions is largely attributed to increasing screen time, which causes digital eye strain, dry eyes, and blurred vision due to prolonged exposure without sufficient breaks. Robotic-assisted eye surgery addresses these disorders by enhancing surgical precision, minimizing human error, and enabling minimally invasive procedures, which improve patient outcomes and shorten recovery times. For example, in May 2024, the Centers for Disease Control and Prevention (CDC), a US government agency, reported that 20.5 million people aged 40 and older in the United States representing 17.2% of that age group were expected to have cataracts in at least one eye in 2024. This figure is projected to exceed 30 million by 2028. As a result, the growing prevalence of eye disorders is fueling the demand for robotic-assisted eye surgery.
Companies in the robotic-assisted eye surgery market are increasingly focused on developing advanced technologies, such as robotic-assisted phacoemulsification platforms, to improve surgical precision, lower complication risks, and enhance patient outcomes. A robotic-assisted phacoemulsification platform is a system that uses robotic technology to assist surgeons in performing cataract removal procedures with greater accuracy. For instance, in May 2024, ForSight Robotics, an Israel-based developer of robotic surgery platforms, introduced the ORYOM surgical robotics platform capable of conducting a complete, remote robotic cataract procedure. The platform features a miniature robotic hand with 14 degrees of freedom and hybrid kinematics, offering superior maneuverability inside the eye. It integrates artificial intelligence, advanced imaging, and compact mechanical components to ensure consistent and precise surgical performance. Additionally, stereoscopic imaging enhances depth perception and provides real-time feedback, while machine learning enables the platform to adapt and improve with each procedure.
In March 2025, Alcon Inc., a Switzerland-based eye care company, acquired LENSAR Inc. for $430 million. This acquisition enables Alcon to leverage LENSAR's advanced laser technology and surgical planning software to deliver more accurate, efficient, and integrated solutions in robotic-assisted cataract surgery. LENSAR Inc. is a US-based provider specializing in robotic-assisted eye surgery.
Major companies operating in the robotic-assisted eye surgery market are Johnson & Johnson, ZEISS Group, Alcon Inc., Intuitive Surgical Operations Inc., Bausch + Lomb Corp., Leica Microsystems, Lumenis Ltd., Topcon Healthcare, IRIDEX Corp., ForSight Robotics Ltd., Prasad Netralaya, Haag-Streit Group, Nidek Co. Ltd., Ophthorobotics AG, Preceyes BV, Horizon Surgical Systems, AcuSurgical, LENSAR Inc., Ziemer Ophthalmic Systems AG, STAAR Surgical Company, Optovue, Glaukos Corporation, Eyenuk, AcuFocus, Avedro Inc., Aeon Astron Europe BV, Omega Ophthalmics
North America was the largest region in the robotic-assisted eye surgery market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the robotic-assisted eye surgery market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
The countries covered in the robotic-assisted eye surgery market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain
The robotic-assisted eye surgery market consists of revenues earned by entities by providing services such as training and support services, tele-surgical support services, data management, maintenance, upgrade services, and remote surgery assistance. The market value includes the value of related goods sold by the service provider or included within the service offering. The robotic-assisted eye surgery market also includes sales of wearable visualization devices, robotic-compatible surgical microscopes, microsurgical instruments, and navigation systems. Values in this market are 'factory gate' values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.
The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).
The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.
Robotic-Assisted Eye Surgery Market Global Report 2026 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.
This report focuses robotic-assisted eye surgery market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.
Where is the largest and fastest growing market for robotic-assisted eye surgery ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward, including technological disruption, regulatory shifts, and changing consumer preferences? The robotic-assisted eye surgery market global report from the Business Research Company answers all these questions and many more.
The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, total addressable market (TAM), market attractiveness score (MAS), competitive landscape, market shares, company scoring matrix, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.
Added Benefits available all on all list-price licence purchases, to be claimed at time of purchase. Customisations within report scope and limited to 20% of content and consultant support time limited to 8 hours.